Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Merck KGaA team discovers new integrin inhibitors for thrombosis, cardiovascular disorders, etc.

Oct. 14, 2003

Merck KGaA scientists discover new factor Xa/factor VIIa inhibitors

Oct. 9, 2003

Successful interim analysis of phase II alfimeprase study

Sep. 30, 2003

OBI-1 undergoes testing in hemophilia A patients

Sep. 30, 2003

Novel TF/factor VIIa inhibitors under study at Roche

Sep. 26, 2003

3DP presents new orally active thrombin inhibitors at ACS meeting

Sep. 25, 2003

Phase IIIa study of Neutralase halted

Sep. 25, 2003

Dual thrombin/factor Xa inhibitors evaluated as anticoagulants

Sep. 23, 2003

Novel benzamidine-based factor Xa inhibitors in Morphochem pipeline

Sep. 22, 2003

BMS-561389/DPC-906 as a phase II candidate for oral anticoagulant therapy

Sep. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...